MedPath

InSpark Technologies, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (100.0%)

A Pilot Study of Nocturnal Hypoglycemia Prevention in Type 1 Diabetes Using the Vigilant Diabetes Management Companion

Not Applicable
Terminated
Conditions
Diabetes Mellitus, Type 1
Hypoglycemia
First Posted Date
2016-09-20
Last Posted Date
2017-03-03
Lead Sponsor
InSpark Technologies, Inc.
Target Recruit Count
13
Registration Number
NCT02906891
Locations
🇺🇸

East Carolina University, Greenville, North Carolina, United States

T1 Diabetes Hypoglycemia Prevention Pilot

Not Applicable
Terminated
Conditions
Hypoglycemia
Diabetes Mellitus, Type 1
First Posted Date
2016-02-17
Last Posted Date
2017-03-03
Lead Sponsor
InSpark Technologies, Inc.
Target Recruit Count
4
Registration Number
NCT02682940
Locations
🇺🇸

Atlanta Diabetes Associates, Atlanta, Georgia, United States

Human Factors and Home Use Study of the Vigilant Diabetes Management Application

Not Applicable
Completed
Conditions
Diabetes Mellitus
First Posted Date
2014-10-28
Last Posted Date
2016-02-24
Lead Sponsor
InSpark Technologies, Inc.
Target Recruit Count
61
Registration Number
NCT02276131

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.